Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 17:17:6017-6030.
doi: 10.2147/JMDH.S481398. eCollection 2024.

Toward Multidisciplinary Tools for Complex Clinical Psychopharmacology Cases: A Qualitative Study with French Healthcare Professionals

Matthieu Lebrat  1   2 , Rachel Megard  1 , Anne-Cecile Gallo Blandin  3 , Nicolas Franck  1   4   5 , Luc Zimmer  2   5   6   7
Affiliations

Toward Multidisciplinary Tools for Complex Clinical Psychopharmacology Cases: A Qualitative Study with French Healthcare Professionals

Matthieu Lebrat et al. J Multidiscip Healthc. .

Abstract

Purpose: Psychopharmacology prescriptions are complex, partly due to the complexity of the relationship between diagnosis and its etiology, as well as the iatrogenic impact on symptomatology. Many multidisciplinary tools exist to optimize their management and improve evidence-based practice. However, their multidisciplinary integration seems to be a challenge. This study aimed to collect information on barriers and facilitators perceived by hospital health professionals regarding the use of multidisciplinary tools to address complex situations in psychopharmacology.

Research design and methods: A mixed-methods research approach using semi-structured interviews was conducted with physicians and pharmacists from 11 hospital institutions. An interview guide developed from the COM-B model (Capability, Opportunity, and Motivation - Behavior) was used to identify barriers and facilitators to the use of multidisciplinary tools. Data were analyzed using thematic analysis to identify emerging themes and mapped to the COM-B model.

Results: 28 professionals were interviewed. Identified barriers were: lack of knowledge and time to address complex situations, incomplete medical records, lack of easily accessible multidisciplinary tools, insufficient levels of evidence in psychopharmacology. Identified facilitators were: continuing education, communication and networking among professionals, implementation of adapted and shared resources, deprescribing, awareness of medication-induced iatrogenesis, accessibility of tools for all populations.

Conclusion: Identified barriers and facilitators in the use of multidisciplinary tools for complex situations in psychopharmacology helped to model factors that enable behavior change. Answers need to be provided to help professionals ensure and optimize psychopharmacological therapies.

Keywords: capability – opportunity - motivation – behavior (COM-B) model; hospitals; mental health; patient care team; psychopharmacology.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Figures

Figure 1
Figure 1
Answers to the question: “In your practice, do you encounter complex therapeutic interventions for which the use of easily accessible classical resources and databases in psychopharmacology (eg, Vidal®, HAS recommendations, etc) does not allow you to address therapeutic questions quickly and reliably?” from n=28 healthcare professionals.
Figure 2
Figure 2
Answers to the question: “Do you sometimes feel lacking reliable and secure information when dealing with therapeutic questions in psychopharmacology?” from n=28 healthcare professionals.
Figure 3
Figure 3
Answers to the question: “In your practice, do you sometimes seek advice from other healthcare professionals to secure and address certain therapeutic interventions?” from n=28 healthcare professionals.
Figure 4
Figure 4
COM-B model.
Figure 5
Figure 5
Answers to the question: “Are there situations where seeking advice from another healthcare professional is not sufficient for the complex psychopharmacological situation?” from n=28 healthcare professionals.
See this image and copyright information in PMC

References

    1. Global Health Data Exchange (GHDx). Institute for health metrics and evaluation. Accessed August 23, 2023. Available from: https://vizhub.healthdata.org/gbd-results.
    1. Laidi C, Blampain-Segar L, Godin O, de Danne A, Leboyer M, Durand-Zaleski I. The cost of mental health: where do we stand in France? Eur Neuropsychopharmacol. 2023;69:87–95. doi:10.1016/j.euroneuro.2023.02.004 - DOI - PubMed
    1. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2133–2161. doi:10.1016/S0140-6736(24)00757-8 - DOI - PMC - PubMed
    1. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry. 2022;9(2):137–150. doi:10.1016/S2215-0366(21)00395-3 - DOI - PMC - PubMed
    1. Aryutova K, Stoyanov D. Pharmaco-magnetic resonance as a tool for monitoring the medication-related effects in the brain may provide potential biomarkers for psychotic disorders. Int J Mol Sci. 2021;22(17):9309. doi:10.3390/ijms22179309 - DOI - PMC - PubMed

LinkOut - more resources